Home / News / FAQ
FAQ

FAQ: HeartBeam Inc.'s New Patents and 3D ECG Technology Advancements

FaqStaq News - Just the FAQs • August 21, 2025
By FAQstaq Staff
Read Original Article →
FAQ: HeartBeam Inc.'s New Patents and 3D ECG Technology Advancements

Summary

HeartBeam Inc. has secured two new U.S. patents that enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology. These patents support the company's innovative 3D ECG platform, which aims to transform cardiac care by enabling remote monitoring and diagnosis outside medical facilities.

What is the main topic of this announcement?

HeartBeam Inc. has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology, specifically advancing its innovative 3D ECG platform.

Why are these new patents significant for HeartBeam?

These patents add to HeartBeam’s growing IP portfolio, which now includes more than 20 U.S. and international patents, enabling the company to expand the reach and impact of its groundbreaking 3D ECG technology in transforming cardiac care.

How does HeartBeam’s 3D ECG technology work?

HeartBeam is creating the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions, designed for use in portable devices that can be used wherever the patient is to deliver actionable heart intelligence.

What is the company’s vision for this technology?

HeartBeam’s vision is to make it easier for patients and physicians to monitor and diagnose cardiac symptoms outside of a medical facility, redefining the future of cardiac health management by providing powerful cardiac insights wherever the patient is.

How many patents does HeartBeam currently hold?

HeartBeam now holds more than 20 U.S. and international patents, with 13 U.S. and 4 international-issued patents specifically related to technology enablement, plus additional applications pending.

Who is the CEO of HeartBeam and what did they say about these patents?

HeartBeam CEO Robert Eno stated that ‘The new patents add to our growing IP portfolio, enabling us to expand the reach and impact of our groundbreaking 3D ECG technology as we strive to transform the future of cardiac care.’

Where can I find more information about HeartBeam Inc.?

For more information, visit www.HeartBeam.com or access the latest news and updates relating to BEAT in the company’s newsroom at https://ibn.fm/BEAT.

What are the practical benefits of HeartBeam’s technology for patients and physicians?

Physicians will be able to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of medical facilities, while patients benefit from portable monitoring that provides powerful, personalized insights into heart health wherever they are.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)

Article Control ID: 172752